デフォルト表紙
市場調査レポート
商品コード
1619035

遺伝子編集の世界市場規模、シェア、成長分析:技術別、提供別、用途別、エンドユーザー別、地域別 - 産業予測(2024年~2031年)

Gene Editing Market Size, Share, Growth Analysis, By Type, By Application, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
遺伝子編集の世界市場規模、シェア、成長分析:技術別、提供別、用途別、エンドユーザー別、地域別 - 産業予測(2024年~2031年)
出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の遺伝子編集の市場規模は、2022年に54億米ドルと評価され、2023年の62億4,000万米ドルから2031年には197億5,000万米ドルに成長し、予測期間中(2024年~2031年)のCAGRは15.5%で成長する見通しです。

世界の遺伝子編集市場は、特にCRISPR-Cas9やTALENのような技術を通じたバイオテクノロジーの進歩により、著しい成長を遂げています。個別化医療の需要と研究開発投資の増加は、遺伝子疾患やがんの治療用途の拡大とともに、この市場の主要促進要因となっています。農業分野でも、作物の収量や病気への耐性を高めるために遺伝子編集が採用されています。製薬会社やバイオテクノロジー会社を含む大手企業は、激しい競争の中で研究能力を拡大するために戦略的提携を行っています。北米は先進的なヘルスケアシステムに支えられて市場をリードしており、アジア太平洋はヘルスケア支出の増加と政府支援に後押しされて大きく成長しようとしています。倫理的・規制的課題にもかかわらず、市場は今後数年で大きく成長すると予想されます。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析と影響
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 供給企業の交渉力

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2023年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • ケーススタディ

遺伝子編集市場規模:技術別、CAGR(2024年~2031年)

  • 市場概要
  • CRISPR
  • TALENs
  • ジンクフィンガーヌクレアーゼ(ZFN)
  • 制限酵素
  • その他

遺伝子編集市場規模:提供別、CAGR(2024年~2031年)

  • 市場概要
  • 製品
    • キット
    • 試薬
    • ライブラリー
    • ソフトウェア
  • サービス
    • gRNA合成
    • ベクトル構築
    • 細胞株エンジニアリング

遺伝子編集市場規模:用途別、CAGR(2024年~2031年)

  • 市場概要
  • 遺伝子工学
    • 動物遺伝子工学
    • 植物遺伝子工学
  • 臨床応用
    • 遺伝子治療
    • 細胞療法
    • 診断
  • 医薬品の創薬と開発
  • 農業

遺伝子編集市場規模:エンドユーザー別、CAGR(2024年~2031年)

  • 市場概要
  • 製薬・バイオテクノロジー企業
  • 学術研究機関
  • 契約研究機関(CRO)
  • その他

遺伝子編集市場規模、CAGR(2024年~2031年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比の比較(2021年~2023年)

主要企業プロファイル

  • CRISPR Therapeutics
  • Editas Medicine
  • Intellia Therapeutics
  • Sangamo Therapeutics
  • Precision BioSciences
  • Beam Therapeutics
  • Cellectis
  • Horizon Discovery Group
  • Bluebird Bio
  • Caribou Biosciences
  • Synthego Corporation
  • Origene Technologies
  • Genscript Biotech Corporation
  • Lonza Group
  • Merck KGaA
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Takara Bio Inc.
  • New England Biolabs
  • Inscripta, Inc.

結論と推奨事項

目次
Product Code: SQMIG35H2103

Global Gene Editing Market size was valued at USD 5.40 billion in 2022 and is poised to grow from USD 6.24 billion in 2023 to USD 19.75 billion by 2031, growing at a CAGR of 15.5% during the forecast period (2024-2031).

The Global Gene Editing Market has seen remarkable growth due to advancements in biotechnology, particularly through technologies like CRISPR-Cas9 and TALENs. The demand for personalized medicine and increased investments in R&D are key drivers of this market, alongside the expanding therapeutic applications for genetic disorders and cancers. The agriculture sector is also embracing gene editing to enhance crop yield and resistance to diseases. Major players, including pharmaceutical and biotechnology companies, are engaged in strategic collaborations to broaden their research capabilities amid intense competition. North America leads the market, backed by advanced healthcare systems, while Asia-Pacific is poised for significant growth fueled by rising healthcare spending and governmental support. Despite ethical and regulatory challenges, the market is expected to grow substantially in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Editing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Editing Market Segmental Analysis

Global Gene Editing Market is segmented by technology, offerings, application, end user and region. Based on technology, the market is segmented into CRISPR, TALENs, zinc finger nucleases (ZFNs), restriction enzymes and others. Based on offerings, the market is segmented into products and services. Based on application, the market is segmented into genetic engineering, clinical applications, drug discovery and development and agriculture. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs) and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gene Editing Market

A major factor propelling the global gene editing market is the rising demand for personalized medicine. Gene editing technologies provide opportunities to craft bespoke therapies and treatments, specifically designed around an individual's unique genetic profile. This customized approach not only promises better treatment effectiveness and fewer side effects but also aims to enhance overall patient health. As awareness of personalized medicine grows, so too does the push for targeted therapies, significantly driving the adoption and progression of gene editing innovations. Consequently, the drive for personalized healthcare solutions is a crucial catalyst in the evolution of the gene editing landscape.

Restraints in the Global Gene Editing Market

A significant restraint in the global gene editing market stems from ethical and regulatory challenges inherent to the technology. The manipulation of genetic material raises intricate ethical dilemmas, especially concerning germline editing and changes that can be passed to future generations. Ongoing debates surrounding the moral implications and potential long-term effects of gene editing further complicate its acceptance. Moreover, the regulatory landscapes governing gene editing practices differ widely across jurisdictions and are in a constant state of flux. The imperative for robust ethical guidelines and unambiguous regulatory frameworks presents a notable obstacle to the market's expansion and broader implementation.

Market Trends of the Global Gene Editing Market

The global gene editing market is increasingly centered on therapeutic applications, significantly driving growth in gene therapies. As advancements in technologies such as CRISPR and TALEN enable precise interventions at the genetic level, there is a heightened focus on addressing genetic disorders, cancers, and other complex diseases through targeted treatments. This shift is catalyzed by a surge in research initiatives and collaborations among biopharmaceutical companies, academic institutions, and healthcare organizations, aimed at unlocking the full potential of gene editing for innovative therapies. The burgeoning interest in personalized medicine underscores the transformative impact of gene editing on the future of healthcare, particularly in meeting unmet medical needs.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies

Global Gene Editing Market Size by Technology & CAGR (2024-2031)

  • Market Overview
  • CRISPR
  • TALENs
  • Zinc Finger Nucleases (ZFNs)
  • Restriction Enzymes
  • Others

Global Gene Editing Market Size by Offerings & CAGR (2024-2031)

  • Market Overview
  • Products
    • Kits
    • Reagents
    • Libraries
    • Software
  • Services
    • gRNA Synthesis
    • Vector Construction
    • Cell Line Engineering

Global Gene Editing Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Genetic Engineering
    • Animal Genetic Engineering
    • Plant Genetic Engineering
  • Clinical Applications
    • Gene Therapy
    • Cell Therapy
    • Diagnostics
  • Drug Discovery and Development
  • Agriculture

Global Gene Editing Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)
  • Others

Global Gene Editing Market Size & CAGR (2024-2031)

  • North America, (Technology, Offerings, Application, End User)
    • US
    • Canada
  • Europe, (Technology, Offerings, Application, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Technology, Offerings, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Technology, Offerings, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Technology, Offerings, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • CRISPR Therapeutics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Editas Medicine
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Intellia Therapeutics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sangamo Therapeutics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Precision BioSciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beam Therapeutics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cellectis
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Horizon Discovery Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bluebird Bio
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Caribou Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Synthego Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Origene Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genscript Biotech Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • New England Biolabs
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inscripta, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation